APOPTOSIS IN BREAST-CANCER AS RELATED TO HISTOPATHOLOGICAL CHARACTERISTICS AND PROGNOSIS

被引:190
|
作者
LIPPONEN, P [1 ]
AALTOMAA, S [1 ]
KOSMA, VM [1 ]
SYRJANEN, K [1 ]
机构
[1] UNIV KUOPIO,DEPT SURG,SF-70211 KUOPIO,FINLAND
关键词
APOPTOSIS; BREAST CANCER; PROGNOSIS;
D O I
10.1016/0959-8049(94)00342-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Appoptotic cells were quantitated by light microscopy in a series of 288 breast carcinomas, and their number (cells/mm(2) of neoplastic epithelium, i.e., the apoptotic index, AI) was related to various histopathological features and disease outcome. High AI was associated with tumour necrosis (P = 0.003), lack of tubule formation (P = 0.03), dense stromal lymphocyte infiltration (P = 0.0009), high grade of the tumour (P < 0.0001), DNA aneuploidy (P = 0.049), high S-phase fraction (P = 0.010), high mitotic rate (P < 0.0001), lack of sex steroid receptors (P = 0.004), expression of p53 tumour suppressor gene (P = 0.004), and high values of morphometrically measured nuclear factors (P < 0.05). In survival analysis, an AI greater than 3/mm(2) was related to short recurrence-free survival in the entire cohort (P = 0.0079) as well as in the axillary lymph node-negative tumours (P = 0.0253). Survival of the patients with node-negative tumours (P = 0.0356), node-positive tumours (P = 0.0085) and in the entire cohort (P = 0.004) was related to AI. Recurrence-free survival was related to the mitotic index (P = 0.0012), ductal type (P = 0.011), S.D. of the nuclear area (P = 0.075), and axillary lymph node status (P = 0.096). Cox's analysis showed that only the tumour diameter (P < 0.001), axillary lymph node status (P = 0.001), progesterone receptor content (P = 0.004) and ductal type (P = 0.041) had independent prognostic value, whereas AI did not.
引用
收藏
页码:2068 / 2073
页数:6
相关论文
共 50 条
  • [41] BREAST-CANCER PROGNOSIS AND ESTROGEN RECEPTORS
    BUCHANANDAVIDSON, DJ
    WISCONSIN MEDICAL JOURNAL, 1979, 78 (01): : 16 - 17
  • [42] BREAST-CANCER - METASTATIC PATTERNS AND THEIR PROGNOSIS
    PATANAPHAN, V
    SALAZAR, OM
    RISCO, R
    SOUTHERN MEDICAL JOURNAL, 1988, 81 (09) : 1109 - 1112
  • [43] LIFE EVENTS AND BREAST-CANCER PROGNOSIS
    BARRACLOUGH, J
    PINDER, P
    CRUDDAS, M
    OSMOND, C
    TAYLOR, I
    PERRY, M
    BRITISH MEDICAL JOURNAL, 1992, 304 (6834): : 1078 - 1081
  • [44] PREOPERATIVE HYDROXYPROLINURIA IN THE PROGNOSIS OF BREAST-CANCER
    DELLANNA, B
    PERCUDANI, M
    DELORENZIS, G
    BULLETIN DU CANCER, 1982, 69 (02) : 177 - 177
  • [45] PROGNOSIS AND TREATMENT IN MINIMAL BREAST-CANCER
    FRAZIER, TG
    COPELAND, EM
    GALLAGER, HS
    PAULUS, DD
    WHITE, EC
    AMERICAN JOURNAL OF SURGERY, 1977, 133 (06): : 697 - 701
  • [46] DNA CONTENT AND PROGNOSIS IN BREAST-CANCER
    DOWLE, CS
    BURNS, K
    ROBINS, A
    OWAINATI, A
    TODD, JH
    ELSTON, CW
    BLAMEY, RW
    BRITISH JOURNAL OF SURGERY, 1985, 72 (12) : 1036 - 1036
  • [47] PROGNOSIS OF BREAST-CANCER ASSOCIATED WITH PREGNANCY
    CLARK, RM
    BMJ-BRITISH MEDICAL JOURNAL, 1991, 302 (6789): : 1401 - 1401
  • [48] AGE AND PROGNOSIS IN PREMENOPAUSAL BREAST-CANCER
    OROURKE, MT
    ELLISON, PT
    LANCET, 1993, 342 (8862): : 60 - 60
  • [49] PERIOPERATIVE HORMONES AND PROGNOSIS IN BREAST-CANCER
    FENTIMAN, IS
    GREGORY, WM
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (12) : 1892 - 1894
  • [50] THERAPY AND PROGNOSIS OF INFLAMMATORY BREAST-CANCER
    KUSCHE, M
    SCHARL, A
    REUSCH, K
    BOLTE, A
    TUMORDIAGNOSTIK & THERAPIE, 1987, 8 (03) : 108 - 114